Robert Jr Laforce

Professeur agrégé de clinique

Laval University

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Medical Science Medical Science professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Robert Jr Laforce is a Clinical Professor at Université Laval in Canada. His research primarily focuses on neurodegenerative disorders, cognitive function, and the implications of cerebrovascular health. Recent publications include studies on genetic frontotemporal dementia, the correlation of retinal imaging with neurodegenerative diagnoses, and the efficacy of treatments for aphasia. He aims to enhance understanding and diagnosis of cognitive impairments across various age groups.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (20)

Arabella Bouzigues

University College London

UNITED KINGDOM

Robert Jr Laforce

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia

Diagnosing neurodegenerative disorders using retina as an external window: A systematic review of OCT-MRI correlations

Expanding the Applicability of Cognitive Charts to the Entire Age Span

Association of Changes in Cerebral and Hypothalamic Structure With Sleep Dysfunction in Patients With Genetic Frontotemporal Dementia

Efficacy of Acetylcholinesterase Inhibitors in the Logopenic Variant of Primary Progressive Aphasia

Persisting chemosensory impairments in 366 healthcare workers following COVID-19: an 11-month follow-up

Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia

Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study

Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1

Heterogeneity of repetition abilities in logopenic variant primary progressive aphasia

Age at symptom onset and death and disease duration in genetic frontotemporal dementia

Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers.

Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer’s Disease

Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration

Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort

A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort

Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34

Comorbid amyloid-β pathology affects clinical and imaging features in VCD

Improvement in functional vocabulary and generalization to conversation following a self-administered treatment using a smart tablet in primary progressive aphasia

Neuronal pentraxin 2: A synapse-derived CSF biomarker in genetic frontotemporal dementia

Collaborators (20)

Arabella Bouzigues

Sara CARAZO PEREZ

Valentina Bessi

Julie Snowden

Nicolas Dupre

Caroline Graff

Liziane Bouvier

Jie Mei

Paola Caroppo

Pietro Tiraboschi

Markus Otto

Laura Monetta

sandro sorbi

Vincent Martel-Sauvageau

Johannes Frasnelli

Juan M. Gorriz

Stuart Pickering-Brown

Barbara Borroni

PEDRO ROSA-NETO

Giorgio G. Fumagalli

Make your next move.